TAYLOR SPERA: Open Payments
NPI 1558734889 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,343 in 76 payments from 14 companies in 2025. Trend: 2023 $1,363 · 2024 $1,705 · 2025 $1,343
Food & beverage: $1,343
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $270 |
| UCB, Inc. | 7 | $204 |
| Novartis Pharmaceuticals Corporation | 16 | $194 |
| Janssen Biotech, Inc. | 5 | $178 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $111 |
| Regeneron Healthcare Solutions, Inc. | 4 | $77 |
| Lilly USA, LLC | 4 | $75 |
| Galderma Laboratories, L.P. | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| LEO Pharma Inc. | 2 | $32 |
Products named: Bimzelx, TREMFYA, RINVOQ, SKYRIZI, Winlevi, COSENTYX, TALTZ, NEMLUVIO.
Industry payments across IN — which companies pay providers there.
